Appendix A — Supplementary validation analyses
A.0.1 Validation of unspecified diabetes in the Health In Central Denmark survey and in the National Health Survey.
Validation analyses performed in the HICD study population from study I:
Table A.1: Supplementary: Validation of uspecified diabetes in the HICD study population
| OSDC | Survey: +DM | Survey: -DM | Total N |
|---|---|---|---|
| OSDC: +DM | 2,512 | 221 | 2,733 |
| OSDC: -DM | 121 | 26,537 | 26,658 |
| Total N | 2,633 | 26,758 | 29,391 |
| Sensitivity | 0.954 (0.945, 0.962) | ||
| Specificity | 0.992 (0.991, 0.993) | ||
| PPV | 0.919 (0.908, 0.929) | ||
| NPV | 0.995 (0.995, 0.996) |
| RSCD | Survey: +DM | Survey: -DM | Total N |
|---|---|---|---|
| RSCD: +DM | 2,422 | 122 | 2,544 |
| RSCD: -DM | 211 | 26,636 | 26,847 |
| Total N | 2,633 | 26,758 | 29,391 |
| Sensitivity | 0.920 (0.909, 0.930) | ||
| Specificity | 0.995 (0.995, 0.996) | ||
| PPV | 0.952 (0.943, 0.960) | ||
| NPV | 0.992 (0.991, 0.993) |
Validation analyses performed among respondents in the National Health Survey 2017 (individuals reporting diabetes as a current disease were considered diabetes cases).
Table A.2: Supplementary: Validation of uspecified diabetes in the National Health Survey
| OSDC | Survey: +DM | Survey: -DM | Total N |
|---|---|---|---|
| OSDC: +DM | 1,630 | 258 | 1,888 |
| OSDC: -DM | 87 | 26,460 | 26,547 |
| Total N | 1,717 | 26,718 | 28,435 |
| Sensitivity | 0.95 (0.94, 0.96) | ||
| Specificity | 0.99 (0.99, 0.99) | ||
| PPV | 0.86 (0.85, 0.88) | ||
| NPV | 1.00 (1.00, 1.00) |
| RSCD | Survey: +DM | Survey: -DM | Total N |
|---|---|---|---|
| RSCD: +DM | 1,546 | 184 | 1,730 |
| RSCD: -DM | 171 | 26,534 | 26,705 |
| Total N | 1,717 | 26,718 | 28,435 |
| Sensitivity | 0.90 (0.89, 0.91) | ||
| Specificity | 0.99 (0.99, 0.99) | ||
| PPV | 0.89 (0.88, 0.91) | ||
| NPV | 0.99 (0.99, 0.99) |